alendronate has been researched along with Diffuse Cutaneous Systemic Sclerosis in 1 studies
alendronic acid : A 1,1-bis(phosphonic acid) that is methanebis(phosphonic acid) in which the two methylene hydrogens are replaced by hydroxy and 3-aminopropyl groups.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Bone resorption was increased in patients with connective tissue disease and severe dystrophic calcification." | 1.32 | Increased bone resorption and failure to respond to antiresorptive therapy in progressive dystrophic calcification. ( Bresnihan, B; FitzGerald, O; Freaney, R; McKenna, M; Murphy, E, 2003) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Murphy, E | 1 |
| Freaney, R | 1 |
| Bresnihan, B | 1 |
| McKenna, M | 1 |
| FitzGerald, O | 1 |
1 other study available for alendronate and Diffuse Cutaneous Systemic Sclerosis
| Article | Year |
|---|---|
Increased bone resorption and failure to respond to antiresorptive therapy in progressive dystrophic calcification.
Topics: Absorptiometry, Photon; Adult; Aged; Alendronate; Biomarkers; Bone Density; Bone Resorption; Calcino | 2003 |